Related Experiment Video
Updated: Mar 29, 2026
Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
Molecular diagnosis: Implications for ophthalmology
James T Rosenbaum1, Cailin H Sibley2, Dongseok Choi3
1Devers Eye Institute, Legacy Health Systems, 1040 NW 22nd Avenue, Portland, OR 97210, USA; Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA; Department of Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.
Precision medicine tailors treatments using individual patient characteristics. Molecular diagnosis applied to orbital inflammatory disease exemplifies this approach for personalized patient care.
Area of Science:
- Ophthalmology
- Genetics
- Immunology
Background:
- Precision medicine aims to individualize patient therapies based on unique characteristics.
- Orbital inflammatory diseases (OIDs) present diverse clinical features requiring tailored treatment strategies.
Purpose of the Study:
- To illustrate the application of molecular diagnostics in achieving precision medicine goals for OIDs.
- To demonstrate how understanding molecular profiles can guide targeted OID therapies.
Main Methods:
- Reviewing the definition and principles of precision medicine.
- Analyzing the role of molecular diagnostics in characterizing OIDs.
- Discussing the potential for targeted therapies based on molecular findings in OIDs.
Main Results:
- Precision medicine redefines patient stratification beyond clinical presentation.
- Molecular diagnosis offers a pathway to identify specific OID subtypes.
- This approach facilitates the development of targeted therapeutic interventions for OIDs.
Conclusions:
- Molecular diagnostics are crucial for implementing precision medicine in OID management.
- Personalized therapeutic strategies for OIDs can be developed through molecular profiling.
- Precision medicine holds significant promise for improving outcomes in OID patients.
